DENALI Study Seeks to Prove Efficacy of Azenosertib in High-Grade Serous Ovarian Cancer
The phase 2 DENALI trial is investigating azenosertib in patients with high-grade serous ovarian cancer.
Source: onclive.com
Stay updated with breaking news from Denali Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The phase 2 DENALI trial is investigating azenosertib in patients with high-grade serous ovarian cancer.
Shannon N. Westin, MD, MPH, FACOG, discusses the DENALI trial of azenosertib in patients with high-grade serous ovarian cancer.